Schizophrenia: Clinical Trials

4 trials for Schizophrenia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 suspended. 4 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Suspended 4
Phase 13Suspended 3

Follow Schizophrenia: new trials by email Literature Review of Schizophrenia trials Research Report on Schizophrenia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
D-serine AudRem: R33 Phase
D-serine, Placebo - Schizophrenia, Schizo Affective Disorder
Phase 1 / Phase 2SuspendedNew York State Psychiatric Institute602022-12-012026-11-02
Accelerated TMS in Psychosis
repetitive Transcranial Magnetic Stimulation (rTMS) - Schizophrenia, Schizoaffective Disorder
Phase 1 / Phase 2SuspendedBeth Israel Deaconess Medical Center202022-11-292026-04-22
Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome
Omega-3 polyunsaturated fatty acids, Xbox aerobic exercise, transcranial direct current stimulation,tDCS - Schizophrenia
Phase 2SuspendedShanghai Mental Health Center1202020-10-012023-04-18
Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophrenia
APN1125, Placebo - Schizophrenia
Phase 1 / Phase 2SuspendedCoMentis302016-04-012016-07-13

Narrower conditions

Psychotic Disorders (2)  ·  Schizotypal Personality Disorder (1)

Broader conditions

Mental Disorders (4)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (4)  ·  Personality Disorders (1)

Interventions

Docosahexaenoic Acids (1)  ·  Olanzapine (1)  ·  Transcranial Direct Current Stimulation (1)  ·  Transcranial Magnetic Stimulation (1)

Sponsors

Beth Israel Deaconess Medical Center (1)  ·  CoMentis (1)  ·  New York State Psychiatric Institute (1)  ·  Shanghai Mental Health Center (1)

Countries

United States (3)  ·  China (1)

Top investigators

David P Walling, PhD (1)  ·  Roscoe O Brady, MD, PhD (1)  ·  Yan Chen (1)

NIH funding

R33MH116093 (1)